Dow opens above 23K. Here are Thursday's stocks to watch: CCK, KMI, URI >>> READ MORE

FDA Warns Docs as More Fake Cancer Drugs Hit U.S.

Counterfeit contains none of the actual drug


The U.S. Food and Drug Administration is advising doctors about another batch of counterfeit drugs.

The FDA says the fake version of the cancer-fighting drug Avastin contains none of the active ingredients, reports the Associated Press. This is the third counterfeit batch of Avastin — made by Roche (PINK:RHHBY) — to be caught this year.

The batches are labeled “Altuzan,” which is the Turkish version of Avastin. Avastin is an injectable cancer-fighting drug used to treat lung, brain, kidney and colon cancers. However, Altuzan is not approved for use in the U.S. at all.

In a release on its website, the FDA says the counterfeit drugs come from one of these companies: Medical King, Pharmacological or Taranis Medical. Any medical professionals with these drugs from these companies should stop using them and contact the FDA immediately.

More stories about drugs:

Article printed from InvestorPlace Media,

©2017 InvestorPlace Media, LLC